Related content

A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia

By Jatoi Aminah   Tirona Marisa   Cha Steven   Alberts Steven   Rowland Kendrith   Morton Roscoe   Nair Suresh   Kardinal Carl   Stella Philip   Mailliard James   Sargent Daniel   Goldberg Richard  

International Journal of Gastrointestinal Cancer, Vol. 32, Iss. 2-3, 2002-12 ,pp. : 115-123

Humana Press, Inc

Access to resources Recommend Favorite

The incidence and prognostic value of HER2 overexpression and cyclin D1 expression in patients with gastric or gastroesophageal junction adenocarcinoma in Israel

By            

Oncology Letters, Vol. 5, Iss. 2, 2013-01 ,pp. : 559-563

Spandidos Publications

Access to resources Recommend Favorite

p53 Mutations in Carcinoma of the Esophagus and Gastroesophageal Junction

By Sengpiel C.   Konig I. R.   Rades D.   Noack F.   Duchrow M.   Schild S. E.   Ludwig D.   Homann N.  

Cancer Investigation, Vol. 27, Iss. 1, 2009-01 ,pp. : 96-104

Informa Healthcare

Access to resources Recommend Favorite

Prognostic Significance of Targetable Angiogenic and Growth Factors in Patients Undergoing Resection for Gastric and Gastroesophageal Junction Cancers

By Park Do   Yoon Changhwan   Thomas Nicholas   Ku Geoffrey   Janjigian Yelena   Kelsen David   Ilson David   Goodman Karyn   Tang Laura   Strong Vivian   Coit Daniel   Yoon Sam  

Annals of Surgical Oncology, Vol. 21, Iss. 4, 2014-04 ,pp. : 1130-1137

Springer Publishing Company

Access to resources Recommend Favorite

Nodal Staging in Adenocarcinoma of the Gastro-Esophageal Junction. Proposal of a Specific Staging System

By Pedrazzani Corrado   Manzoni Giovanni  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 299-305

Springer Publishing Company

Access to resources Recommend Favorite